INS and dementia: Certain combinations, such as a DPP4i + SU or DPP4i + insulin were significantly associated with dementia severity, while others, such as α-glucosidase inhibitors, TZD + insulin, or TZD + insulin + SU, showed no association when adequate metabolic control was achieved (HbA1c < 7%) [392].